FARALLON CAPITAL MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 196 filers reported holding SAGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$880,824
-96.6%
42,800
-87.6%
0.00%
-96.9%
Q1 2021$25,823,000
-71.6%
345,000
-67.1%
0.13%
-76.6%
Q4 2020$90,836,000
+41.5%
1,050,0000.0%0.55%
+23.0%
Q3 2020$64,176,000
+81.6%
1,050,000
+23.5%
0.44%
+56.9%
Q2 2020$35,343,000
+82.3%
850,000
+25.9%
0.28%
+70.5%
Q1 2020$19,386,000
-46.3%
675,000
+35.0%
0.17%
-32.0%
Q4 2019$36,095,000
-31.0%
500,000
+34.1%
0.24%
-38.2%
Q3 2019$52,300,000
-42.9%
372,800
-25.4%
0.40%
-33.6%
Q2 2019$91,545,000
-4.1%
500,000
-16.7%
0.60%
-17.1%
Q1 2019$95,430,000
+149.1%
600,000
+50.0%
0.72%
+155.5%
Q4 2018$38,316,000
-56.6%
400,000
-36.0%
0.28%
-46.1%
Q3 2018$88,281,000
-9.8%
625,0000.0%0.52%
-13.7%
Q2 2018$97,831,000
+36.5%
625,000
+40.4%
0.60%
+21.8%
Q1 2018$71,676,000
+8.8%
445,000
+11.2%
0.50%
-7.3%
Q4 2017$65,884,000
+334.3%
400,000
+64.3%
0.54%
+296.3%
Q3 2017$15,170,000
+90.5%
243,500
+143.5%
0.14%
+62.7%
Q2 2017$7,964,000100,0000.08%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders